Search Results - "Buděšínský, Tomáš"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study by Kočka, Viktor, Toušek, Petr, Kozel, Martin, Buono, Andrea, Hajšl, Martin, Lisa, Libor, Buděšínský, Tomáš, Malý, Martin, Widimský, Petr

    Published in Journal of translational medicine (30-01-2020)
    “…Bioresorbable scaffold (BRS) Absorb™ clinical use has been stopped due to higher rate of device thrombosis. Scaffold struts persist longer than 2 years in the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19' by Kočka, Viktor, Malý, Martin, Toušek, Petr, Buděšínský, Tomas, Lisa, Libor, Prodanov, Petko, Jarkovský, Jiri, Widimský, Petr

    Published in European heart journal (01-03-2014)
    “…Bioresorbable vascular scaffolds (BVSs) have been studied in chronic coronary artery disease, but not in acute ST-segment elevation myocardial infarction…”
    Get full text
    Journal Article
  4. 4

    Immune–inflammatory response after bioresorbable vascular scaffold implantation in patients with acute myocardial infarction with ST elevation in a long-term perspective by Kozel, Martin, Kočka, Viktor, Lisa, Libor, Buděšínský, Tomáš, Toušek, Petr

    Published in Heart and vessels (01-04-2019)
    “…A higher rate of bioresorbable vascular scaffold (BVS) thrombosis has been observed after device implantation compared to implantation of permanent metallic…”
    Get full text
    Journal Article
  5. 5

    Fully absorbable drug eluting coronary stent: where do we stand in 2014? by Kočka, Viktor, Toušek, Petr, Lisa, Libor, Buděšínský, Tomáš

    Published in Vnitřní lékar̆stvĭ (01-04-2014)
    “…Coronary stent is routinely used in majority percutaneous coronary interventions for a long time. They have an important role, especially, in the first months…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Shock Index: A Simple Clinical Parameter for Quick Mortality Risk Assessment in Acute Myocardial Infarction by Bilkova, Dana, MD, Motovska, Zuzana, MD, PhD, Widimsky, Petr, MD, DrSc, FESC, Dvorak, Jaroslav, MD, Lisa, Libor, MD, Budesinsky, Tomas, MD

    Published in Canadian journal of cardiology (01-11-2011)
    “…Abstract Background Primary percutaneous coronary intervention (PCI) has become the preferred reperfusion strategy in patients with ST-segment elevation…”
    Get full text
    Journal Article
  9. 9

    Might simplification of transcatheter aortic valve implantation reduce the burden on hospital resources? by Kratochvílová, Lenka, Mašek, Petr, Neuberg, Marek, Nováčková, Markéta, Toušek, Petr, Sulženko, Jakub, Buděšínský, Tomáš, Kočka, And Viktor

    Published in European heart journal supplements (01-04-2022)
    “…Transcatheter aortic valve implantation (TAVI) varies considerably in terms of the procedural approach taken and the hospital length of stay (LoS); both…”
    Get full text
    Journal Article
  10. 10

    Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update by Toušek, Petr, Kočka, Viktor, Malý, Martin, Kozel, Martin, Petr, Robert, Hajsl, Martin, Jarkovský, Jiří, Lisa, Libor, Buděšínský, Tomáš, Widimský, Petr

    Published in EuroIntervention (01-05-2016)
    “…Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-elevation myocardial infarction (STEMI) are encouraging, but…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study by Toušek, Petr, Kočka, Viktor, Malý, Martin, Lisa, Libor, Buděšínský, Tomáš, Widimský, Petr

    Published in Heart and vessels (01-06-2016)
    “…Incomplete stent apposition and uncovered struts are associated with a higher risk of stent thrombosis. No data exist on the process of neointimal coverage and…”
    Get full text
    Journal Article
  13. 13

    Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial by Loffi, Marco, Tousek, Petr, Budesinsky, Tomas, Lisa, Libor, Santangelo, Andrea, Widimsky, Petr, Kocka, Viktor

    Published in Heart and vessels (01-11-2018)
    “…This study assessed the Optical Coherence Tomography (OCT) impact on the coronary flow in ST-elevation myocardial infarction (STEMI) after bioresorbable…”
    Get full text
    Journal Article
  14. 14

    Takotsubo Cardiomyopathy: One More Angiographic Evidence of Microvascular Dysfunction by Tousek, Petr, Budesinsky, Tomas, Kocka, Viktor, Kozel, Martin, Santangelo, Andrea, Loffi, Marco, Lisa, Libor

    Published in BioMed research international (01-01-2018)
    “…Background. Takotsubo cardiomyopathy (TC) aetiology has not been completely understood yet. One proposed pathogenic mechanism was coronary microvascular…”
    Get full text
    Journal Article
  15. 15

    Abstract 13551: Invasive Hemodynamic Assessment of Cardiac Output State After MitraClip Therapy by Bednar, Frantisek, Kocka, Viktor, Budesinsky, Tomas, Linkova, Hana, Tousek, Petr

    Published in Circulation (New York, N.Y.) (10-11-2015)
    “…IntroductionMitraClip therapy has become a therapeutic alternative for high surgical risk patients with symptomatic mitral regurgitation (MR). There are…”
    Get full text
    Journal Article
  16. 16

    Invasive Hemodynamic Assessment of Cardiac Output State after MitraClip Therapy in Nonanaesthetized Patients with Functional Mitral Regurgitation by Kocka, Viktor, Linkova, Hana, Budesinsky, Tomas, Bednar, Frantisek

    Published in BioMed research international (01-01-2016)
    “…Background. Surgical correction of mitral regurgitation (MR) can lead to postoperative low cardiac output state. We aimed to assess the acute hemodynamic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial by Widimsky, Petr, Straka, Zbynek, Stros, Petr, Jirasek, Karel, Dvorak, Jaroslav, Votava, Jan, Lisa, Libor, Budesinsky, Tomas, Kolesar, Miroslav, Vanek, Tomas, Brucek, Petr

    Published in Circulation (New York, N.Y.) (30-11-2004)
    “…Off-pump coronary bypass surgery has become a widely used technique during recent years. However, limited data are available with regard to 1-year patency of…”
    Get full text
    Journal Article
  19. 19